TERN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 15.10%

Insider Buying (Last 12 Months): $5,124,566.10

Insider Selling (Last 12 Months): $1,052,698.51

Terns Pharmaceuticals Insider Trading History Chart

Terns Pharmaceuticals Share Price & Price History

^$2.14

+0.30 (1.20%)

As of 04/11/2025 05:00 PM ET

Days: 30 | 90 | 365

Terns Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/1/2025	Emil Kuriakose	Insider	Sell	952	$2.49	$2,370.48	53,317
1/6/2025	Jill M. Quigley	Director	Sell	8,760	$5.79	$50,720.40
1/6/2025	Mark J Vignola	CFO	Sell	9,059	$5.80	$52,542.20	74,752
1/2/2025	Emil Kuriakose	Insider	Sell	4,481	$5.71	$25,586.51	54,269
1/2/2025	Jill M Quigley	Director	Sell	6,240	$5.72	$35,692.80	8,760
1/2/2025	Mark J Vignola	CFO	Sell	8,129	$5.72	$46,497.88	83,811
12/5/2024	Amy L Burroughs	CEO	Buy	15,450	$7.15	$110,467.50	19,099
11/30/2024	Amy L Burroughs	CEO	Buy	510	$5.11	$2,606.10	19,609
11/30/2024	Melita Sun Jung	Insider	Buy	2,250	$5.11	$11,497.50	2,250
9/12/2024	Hongbo Lu	Director	Buy	476,190	$10.50	$4,999,995.00	476,190
9/10/2024	Mark J Vignola	CFO	Sell	10,000	$11.00	$110,000.00	91,940
9/9/2024	Jill M Quigley	Director	Sell	17,235	$10.00	$172,350.00	15,000
8/1/2024	Jill M Quigley	Director	Sell	6,143	$7.68	$47,178.24	23,857
7/15/2024	Carl L Gordon	Director	Sell	50,976	$10.00	$509,760.00	756,258
4/3/2024	Vivo Opportunity, Llc	Major Shareholder	Sell	138,066	$6.20	$856,009.20	268,573
4/1/2024	Vivo Opportunity, Llc	Major Shareholder	Sell	181,117	$6.99	$1,266,007.83	275,772
12/23/2022	Orbimed Advisors Llc	Director	Buy	137,931	$7.25	$999,999.75	4,882,854
12/23/2022	Vivo Opportunity, Llc	Major Shareholder	Buy	758,620	$7.25	$5,499,995.00	4,340,212
11/23/2022	Biosciences Fund V L.P. Lav	Major Shareholder	Sell	1,500,000	$5.50	$8,250,000.00	405,583
9/7/2022	Vivo Opportunity, Llc	Major Shareholder	Buy	600,000	$3.60	$2,160,000.00	3,581,592
8/16/2022	Hongbo Lu	Director	Buy	1,500,000	$2.42	$3,630,000.00	2,981,592
8/15/2022	Vivo Opportunity, Llc	Major Shareholder	Buy	1,218	$2.99	$3,641.82	1,481,592
8/12/2022	Vivo Opportunity, Llc	Major Shareholder	Buy	1,123,021	$2.98	$3,346,602.58	1,480,374

See Full Table

SEC Filings (Institutional Ownership Changes) for Terns Pharmaceuticals (NASDAQ:TERN)

98.26% of Terns Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Terns Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/11/2025	E. Ohman J or Asset Management AB	102,410	$0.28M	0.0%	+27.4%	0.117%
4/10/2025	Thrive Wealth Management LLC	10,500	$29K	0.0%	N/A	0.012%
2/26/2025	Infinitum Asset Management LLC	200,000	$1.11M	0.6%	N/A	0.235%
2/17/2025	Voloridge Investment Management LLC	59,720	$0.33M	0.0%	-62.2%	0.070%
2/17/2025	VR Adviser LLC	1,077,090	$5.97M	0.4%	-68.4%	1.268%
2/17/2025	Woodline Partners LP	311,612	$1.73M	0.0%	+3.4%	0.367%
2/17/2025	Velan Capital Investment Management LP	17,000	$94K	0.1%	N/A	0.020%
2/17/2025	Soleus Capital Management L.P.	8,142,500	$45.11M	2.8%	+30.8%	9.586%
2/17/2025	Squarepoint Ops LLC	13,125	$73K	0.0%	-75.5%	0.015%
2/17/2025	Two Sigma Investments LP	94,689	$0.53M	0.0%	-34.4%	0.111%
2/17/2025	Tema Etfs LLC	79,696	$0.44M	0.2%	N/A	0.094%
2/17/2025	Sherbrooke Park Advisers LLC	17,846	$99K	0.0%	N/A	0.021%
2/17/2025	Point72 Asset Management L.P.	1,251,841	$6.94M	0.0%	-53.8%	1.474%
2/17/2025	ProShare Advisors LLC	23,821	$0.13M	0.0%	+58.4%	0.028%
2/17/2025	Parkman Healthcare Partners LLC	829,105	$4.59M	0.6%	+51.9%	0.976%
2/17/2025	Nuveen Asset Management LLC	2,633,918	$14.59M	0.0%	+30.6%	3.101%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	140,300	$0.78M	0.1%	+192.3%	0.165%
2/17/2025	Millennium Management LLC	1,610,215	$8.92M	0.0%	-1.1%	1.896%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	39,784	$0.22M	0.0%	+26.2%	0.047%
2/17/2025	Integral Health Asset Management LLC	450,000	$2.49M	0.2%	+50.0%	0.530%
2/17/2025	J. Goldman & Co LP	235,831	$1.31M	0.0%	+15.6%	0.278%
2/17/2025	Graham Capital Management L.P.	132,999	$0.74M	0.0%	+897.1%	0.157%
2/17/2025	D. E. Shaw & Co. Inc.	57,341	$0.32M	0.0%	+53.0%	0.068%
2/17/2025	Deutsche Bank AG	398,379	$2.21M	0.0%	-26.6%	0.469%
2/17/2025	Driehaus Capital Management LLC	1,661,846	$9.21M	0.1%	-20.6%	1.956%
2/17/2025	Crestline Management LP	66,599	$0.37M	0.0%	N/A	0.078%
2/17/2025	Cubist Systematic Strategies LLC	11,964	$66K	0.0%	-93.6%	0.014%
2/17/2025	Bank of America Corp DE	197,226	$1.09M	0.0%	+236.8%	0.232%
2/17/2025	Bellevue Group AG	1,061,753	$5.88M	0.1%	+1.9%	1.250%
2/17/2025	BNP Paribas Financial Markets	224,265	$1.24M	0.0%	N/A	0.264%
2/17/2025	Acorn Capital Advisors LLC	1,971,264	$10.92M	6.0%	N/A	2.321%
2/17/2025	Acuta Capital Partners LLC	447,500	$2.48M	2.5%	-8.1%	0.527%
2/14/2025	Boxer Capital Management LLC	752,000	$4.17M	0.4%	N/A	0.885%
2/14/2025	Schonfeld Strategic Advisors LLC	4,751,506	$26.32M	0.2%	+44.4%	5.594%
2/14/2025	Northern Trust Corp	591,171	$3.28M	0.0%	+27.4%	0.696%
2/14/2025	The Manufacturers Life Insurance Company	24,378	$0.14M	0.0%	-63.1%	0.029%
2/14/2025	Oxford Asset Management LLP	15,456	$86K	0.0%	N/A	0.018%
2/14/2025	Nebula Research & Development LLC	25,849	$0.14M	0.0%	+128.2%	0.030%
2/14/2025	Price T Rowe Associates Inc. MD	1,504,238	$8.34M	0.0%	+1.9%	1.771%
2/14/2025	Diadema Partners LP	50,370	$0.28M	0.1%	N/A	0.059%
2/14/2025	Hsbc Holdings PLC	35,898	$0.20M	0.0%	+216.1%	0.042%
2/14/2025	MetLife Investment Management LLC	43,760	$0.24M	0.0%	+27.7%	0.052%
2/14/2025	Dimensional Fund Advisors LP	1,302,932	$7.22M	0.0%	+107.0%	1.534%
2/14/2025	Altium Capital Management LLC	475,000	$2.63M	0.7%	+43.9%	0.559%
2/13/2025	Marshall Wace LLP	803,336	$4.45M	0.0%	+666.8%	0.946%
2/13/2025	Jump Financial LLC	62,401	$0.35M	0.0%	+52.2%	0.073%
2/13/2025	Walleye Capital LLC	118,896	$0.66M	0.0%	-36.0%	0.140%
2/13/2025	Barclays PLC	704,371	$3.90M	0.0%	+444.7%	0.829%
2/13/2025	Townsquare Capital LLC	13,809	$76K	0.0%	N/A	0.016%
2/13/2025	Martingale Asset Management L P	98,106	$0.54M	0.0%	+32.4%	0.116%
2/13/2025	Renaissance Technologies LLC	623,134	$3.45M	0.0%	+30.0%	0.734%
2/13/2025	Invesco Ltd.	23,400	$0.13M	0.0%	+13.3%	0.028%
2/13/2025	Polymer Capital Management HK LTD	177,000	$0.98M	0.2%	+637.5%	0.208%
2/13/2025	Russell Investments Group Ltd.	628,395	$3.48M	0.0%	-15.6%	0.740%
2/13/2025	Wells Fargo & Company MN	40,966	$0.23M	0.0%	+56.8%	0.048%
2/12/2025	Landscape Capital Management L.L.C.	13,196	$73K	0.0%	N/A	0.016%
2/12/2025	ExodusPoint Capital Management LP	10,816	$60K	0.0%	-99.3%	0.013%
2/12/2025	Cinctive Capital Management LP	109,997	$0.61M	0.0%	-34.7%	0.130%
2/12/2025	Trexquant Investment LP	253,247	$1.40M	0.0%	-16.7%	0.298%
2/12/2025	Geode Capital Management LLC	1,516,478	$8.40M	0.0%	+25.6%	1.785%
2/12/2025	Alliancebernstein L.P.	362,359	$2.01M	0.0%	+48.2%	0.427%
2/12/2025	Orion Portfolio Solutions LLC	22,211	$0.12M	0.0%	N/A	0.026%
2/12/2025	Norges Bank	849,389	$4.71M	0.0%	N/A	1.000%
2/12/2025	NEOS Investment Management LLC	79,696	$0.44M	0.0%	-37.9%	0.094%
2/12/2025	JPMorgan Chase & Co.	51,830	$0.29M	0.0%	-70.4%	0.061%
2/11/2025	EntryPoint Capital LLC	60,388	$0.34M	0.1%	N/A	0.071%
2/11/2025	Corebridge Financial Inc.	34,951	$0.19M	0.0%	+13.5%	0.041%
2/11/2025	Vanguard Group Inc.	3,869,582	$21.44M	0.0%	+15.3%	4.556%
2/11/2025	LPL Financial LLC	252,325	$1.40M	0.0%	+397.2%	0.297%
2/11/2025	American Century Companies Inc.	113,225	$0.63M	0.0%	+33.4%	0.133%
2/10/2025	Connor Clark & Lunn Investment Management Ltd.	74,858	$0.42M	0.0%	+41.2%	0.088%
2/7/2025	HighTower Advisors LLC	84,430	$0.47M	0.0%	N/A	0.099%
2/7/2025	Candriam S.C.A.	2,153,969	$11.93M	0.1%	N/A	2.536%
2/6/2025	Charles Schwab Investment Management Inc.	206,450	$1.14M	0.0%	+33.4%	0.243%
2/4/2025	Bank of New York Mellon Corp	186,308	$1.03M	0.0%	+15.4%	0.219%
2/4/2025	Y Intercept Hong Kong Ltd	67,002	$0.37M	0.0%	+84.1%	0.079%
1/30/2025	Rhumbline Advisers	97,892	$0.54M	0.0%	+16.0%	0.115%
1/29/2025	Savant Capital LLC	16,083	$89K	0.0%	N/A	0.019%
1/28/2025	Stoneridge Investment Partners LLC	20,603	$0.11M	0.0%	N/A	0.024%
1/27/2025	Bleakley Financial Group LLC	48,296	$0.27M	0.0%	+262.8%	0.057%
1/27/2025	E. Ohman J or Asset Management AB	80,378	$0.45M	0.0%	+30.1%	0.095%
1/24/2025	China Universal Asset Management Co. Ltd.	18,010	$100K	0.0%	+33.1%	0.021%
1/21/2025	Exchange Traded Concepts LLC	142,919	$0.79M	0.0%	+34.1%	0.168%
1/17/2025	SG Americas Securities LLC	33,333	$0.19M	0.0%	+40.0%	0.039%
1/13/2025	Salem Investment Counselors Inc.	346,725	$1.92M	0.1%	-7.9%	0.408%
11/20/2024	Virtu Financial LLC	62,216	$0.52M	0.0%	+110.2%	0.073%
11/16/2024	Geode Capital Management LLC	1,207,479	$10.07M	0.0%	+7.6%	1.422%
11/15/2024	Y Intercept Hong Kong Ltd	36,392	$0.30M	0.0%	-42.7%	0.043%
11/15/2024	XTX Topco Ltd	17,696	$0.15M	0.0%	N/A	0.021%
11/15/2024	Wellington Management Group LLP	222,065	$1.85M	0.0%	-0.9%	0.261%
11/15/2024	State Street Corp	1,116,991	$9.32M	0.0%	-5.1%	1.315%
11/15/2024	Point72 Asset Management L.P.	2,707,515	$22.58M	0.1%	+0.6%	3.188%
11/15/2024	Polymer Capital Management HK LTD	24,000	$0.20M	0.0%	N/A	0.028%
11/15/2024	Parkman Healthcare Partners LLC	545,751	$4.55M	0.6%	+39.8%	0.643%
11/15/2024	Ikarian Capital LLC	308,497	$2.57M	0.3%	-32.7%	0.363%
11/15/2024	HighVista Strategies LLC	130,966	$1.09M	0.4%	-11.6%	0.154%
11/15/2024	Cinctive Capital Management LP	168,564	$1.41M	0.1%	N/A	0.198%
11/14/2024	Bellevue Group AG	1,042,135	$8.69M	0.1%	N/A	1.482%
11/14/2024	PDT Partners LLC	37,987	$0.32M	0.0%	-52.7%	0.054%
11/14/2024	Sio Capital Management LLC	10,000	$83K	0.0%	N/A	0.014%

Data available starting January 2016

See Full Table

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology, metabolic dysfunction-associated steatohepatitis (MASH), and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of MASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.

Today's Range

Now: $2.14

$2.04

$2.21

50 Day Range

MA: $3.36

$2.00

$4.66

52 Week Range

Now: $2.14

$1.87

$11.40

Volume

1,046,268 shs

Average Volume

1,505,966 shs

Market Capitalization

$186.82 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Terns Pharmaceuticals?: Terns Pharmaceuticals' top insider shareholders include:
Carl L Gordon (Director)
Hongbo Lu (Director)
Vivo Opportunity, Llc (Major Shareholder)
Mark J Vignola (CFO)
Emil Kuriakose (Insider)
Jill M Quigley (Director)
Amy L Burroughs (CEO)
Melita Sun Jung (Insider)
Jill M Quigley (Director)
Learn More about top insider investors at Terns Pharmaceuticals.
Who are the major institutional investors of Terns Pharmaceuticals?: Terns Pharmaceuticals' top institutional shareholders include:
E. Ohman J or Asset Management AB — 0.12%
Thrive Wealth Management LLC — 0.01%
Learn More about top institutional investors of Terns Pharmaceuticals stock.
Which institutional investors are buying Terns Pharmaceuticals stock?: Within the last quarter, TERN stock was purchased by institutional investors including:
E. Ohman J or Asset Management AB
Thrive Wealth Management LLC
During the previous year, these company insiders have bought Terns Pharmaceuticals stock:
Carl L Gordon (Director)
Hongbo Lu (Director)
Vivo Opportunity, Llc (Major Shareholder)
Learn More investors buying Terns Pharmaceuticals stock.